Objective—To determine the effect of recombinant canine somatotropin (STH) on radiographic, densitometric, and biomechanical aspects of bone healing using an unstable ostectomy gap model.
Study Design—After an ostectomy of the midshaft radius, bone healing was evaluated over an 8–week period in control dogs (n = 4) and dogs receiving recombinant canine STH (n = 4).
Animals or Sample Population—Eight sexually intact female Beagle dogs, 4 to 5 years old. Methods—Bone healing was evaluated by qualitative and quantitative evaluation of serial radiographs every 2 weeks. Terminal dual-energy x-ray absorptiometry and three-point bending biomechanical testing were also performed.
Results—Dogs receiving STH had more advanced radiographic healing of ostectomy sites. Bone area, bone mineral content, and bone density were two to five times greater at the ostectomy sites of treated dogs. Ultimate load at failure and stiffness were three and five times greater in dogs receiving STH.
Conclusions—Using the ostectomy gap model, recombinant canine STH enhanced the radiographic, densitometric, and biomechanical aspects of bone healing in dogs. Clinical Relevance—Dogs at risk for delayed healing of fractures may benefit from treatment with recombinant canine STH.
- fracture healing,
- bone callus,
Available at: http://works.bepress.com/joseph_weigel/1/